Implied volatility shows how much movement the market is expecting in the future. Options with high levels of implied ...

Patients adherent to SUBLOCADE® for 12 months had 42% lower adjusted non-MOUD medical costs vs. those adherent to other forms of MOUDPatients ...

Indivior (NASDAQ:INDV) executives told investors the company’s 2025 performance reflected a “transition year” marked by ...

Indivior has picked Havas as its primary partner for engaging healthcare professionals and patients in the U.S.  | Havas will ...

Indivior Pharmaceuticals, Inc. (Nasdaq: INDV) today announced that it will participate in the following upcoming investor conferences: Joe Ciaffoni, Chief Executive Officer, will host 1x1 / group ...

Indivior, a pharmaceutical company, has reached a $30 million settlement to resolve a class action lawsuit filed in a U.S. court by health plans. The lawsuit alleges that the company unlawfully ...

ALBANY - More than a year after the office of New York Attorney General Letitia James reached an $86 million settlement with drugmaker Indivior over its alleged role in fueling the state's opioid ...

Q4 2025 Management View CEO Joseph Ciaffoni stated that 2025 was a transition year, highlighting the successful completion of Phase I Generate Momentum and the delivery of record net revenue for ...

Update 3:15pm: Updates shares, adds investor letter, company response. Indivior PLC (NASDAQ:INDV) soared 13% amid some takeover speculation as well as a letter from one of its largest holders. Oaktree ...

Shares in Indivior Plc (NASDAQ: INDV) were up by 15.5% at 1 p.m. ET today after management released an excellent set of third-quarter results, upgraded its full-year guidance, and served notice that ...

With a $385 million settlement, Suboxone maker Indivior is moving to wrap up years of antitrust litigation tied to its opioid addiction treatment. The company will shell out the money to resolve ...

The AGs had claimed that Invidior used 'product hopping' to block competition from generics for its opioid treatment drug. Drugmaker Invidior PLC says it will pay $102.5 million to 41 states and the ...